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5-Ethyl-3ʹ,5ʹ-O-t-butyldimethylsilyl-2ʹ-deoxycytidine (4):
Compound 3 (0.548 g, 1.14 mmol) was dried overnight under high vacuum and was dissolved in 20 mL of anhydrous MeOH by gently warming it in a warm water bath. The flask was capped and the solution was purged with Ar by bubbling. To this was quickly added 0.35 mol equivalents of 10% Pd-C (0.042 g, 0.4 mmol) and the reaction was stirred under hydrogen for 24 hr. at room temperature. The reaction was monitored by TLC, 
4-N-Benzoyl-5-ethyl-3ʹ,5ʹ-O-t-butyldimethylsilyl-2ʹ-deoxycytidine (5):
Compound 4 (0.125 g, 0.258 mmol) which was dried overnight under high vacuum was co-evaporated three times with 5 mL each of anhydrous pyridine. This compound was then dissolved in 5 mL of anhydrous pyridine and the flask was immediately capped with a rubber septum under argon atmosphere. To the mixture was added 60 µL (0.516 mmol, 2.0 equiv) of benzoyl chloride over a period of 5 minutes at room temperature and the reaction was stirred. The reaction was monitored by TLC (30:1 DCM:MeOH) every ½ hour. Since the reaction still had a lot of starting material remaining after 2 hours, another 40 µL (0.34 mmol, 1.3 equiv) of benzoyl chloride was added and reaction was monitored for another 2 hours, until all starting material was consumed. At the end of the reaction the solvent was removed under reduced pressure, the crude product was taken up in DCM, and the organic layer was washed three times with 50 mL water followed by drying with anhydrous Na 2 SO 4 and the solvent removed under reduced pressure. The crude product was purified on a silica column, using 30: , J = 3.5 Hz). 13 3ʹ-(2-cyanoethyl) placed with a magnetic stir bar in a Teflon tube, which had been chilled on ice for 30 min. The Teflon tube was capped and placed in a stainless steel bomb that was then sealed. The bomb was placed in an oil bath preheated to 75 °C and allowed to react for 3 days. After cooling the stainless steel bomb to below room temperature, the bomb was opened, and the remaining ammonia was allowed to evaporate overnight. The residue was dissolved in 50:50
4-N-Benzoyl-3ʹ,5ʹ-O-(t-butyldimethylsilyl)-5-vinyl-2ʹ-deoxycytidine

4-N-Benzoyl-5ʹ-O-(dimethoxytrityl)-5-vinyl-2ʹdeoxycytidine
MeOH:DCM and dried prior to reverse phase HPLC purification on an Agilent 1100 system. Purification was done using a Synergi 4u Hydro-RP 80A column [250 mm x 4.6 mm] from Phenomenex (Torrance, CA). The starting material and product were eluted isocratically using 6% MeOH in 10 mM Ammonium formate at pH 4.2 for 32 min followed by an increase to 50% ACN and subsequent equilibration to initial conditions. The product eluted at 12.5 min and starting material at 20.9 min. The desired product was desalted using Carbograph SPE cartridges (Grace Analytical, Deerfield, IL) conditioned in MeOH and then water, the product loaded onto the cartridge, followed by a water wash and 3 successive methanol elutions. Product identity was confirmed by matching the UV spectra to a commercial The oligodeoxynucleotides were purified by reversed phase HPLC using an Agilent 1100 system interfaced with a UV-VWD detector 2, 3 . The oligodeoxynucleotides containing modified cytosine base were purified on a Supelcosil LC-18-DB column (10 mm × 250 mm, 5 m, Supelco, Bellefonte, PA) eluted at 40C and a flow rate of 3 mL/min. HPLC buffers were 100 mM triethylammonium acetate, pH 7.0 (A), and acetonitrile (B). A linear gradient of 16.8-26% B in 21 minutes followed by a gradient increase to 34% B in the next 19 minutes was used. Following HPLC purification, the oligodeoxynucleotides were desalted by NAP-5-illustra™ size exclusion columns (GE Healthcare, Piscataway, NJ) according to the manufacturer's protocols. The presence of C5-alkyl-dC in the oligodeoxynucleotides was confirmed by capillary HPLC-ESI --MS (Table S1) , [3] [4] [5] and their concentrations were determined from the extent of 2'-deoxyguanosine in enzymatic digests using previously published protocols. [6] [7] [8] Double stranded DNA was obtained by combining equal amounts of the complementary strands (200 pmol)
in 10 mM Tris-HCl (pH 8.0), 50 mM sodium chloride buffer to achieve a concentration of 200 M. The DNA mixtures were heated at 90°C for 5 mins and then allowed to cool slowly to room temperature. Each duplex contained a 15 N 3 , 13 C 1 -labeled guanine at the first position of codon 157, base paired to cytosine or a C5-alkylcytosine analog (Table   S1 ). 9 
DNA Methyltransferase Experiments
HPLC-ESI + -MS/MS of 5-methyl-dC
where the V max is the maximal methylation rate of DNA by DNMT1, and K m is the concentration of substrate required to reach the half-maximal rate. Statistical differences in V max were calculated in GraphPad Prism using ANOVA using Tukey correction for multiple testing.
Homology Modeling
All molecular modeling was performed using the Schrödinger modeling suite package. 10 Since both the mouse and human DNMT1 shared an 85% sequence similarity 11 , homology modeling of the human DNMT1 (hDNMT1) was carried out using the published crystal structure of the mouse DNMT1 in complex with hemi-methylated DNA (PDB: 4DA4) 12 based on its reference sequence (NP_001124295.1). This method 13, 14 takes advantage of the observation that protein structure is more highly conserved than its amino acid sequence, and that small or medium changes in sequence normally result in little variation in the 3D structure. 15 The DNA sequence was modified accordingly to match the sequence used experimentally to determine DNA methylation rates. Schrödinger Maestro (Schrödinger, LLC, NY) was used to model the extended forms of 5-methylcytosine (5-ethyl-dC, 5-propyl-dC, 5-vinyl-dC) within the modeled DNA template. Each of the modeled hDNMT1 -DNA complexes was subjected to standard protein preparation protocols at physiological pH, followed by energy minimization of the hydrogen atoms using OPLS3 force field with Generalized Born implicit solvent model to optimize all hydrogen-bonding networks. 16, 17 To understand local structural effects induced by oxidation on 5-methylcytosine to ethyl C, propyl C, and vinyl C, energy minimization of the modified base was carried out with a 15Å spherical radius restraint. 83.0 ± 0.8 a 9.7 μM dsDNA in 50 mM NaCl, 10 mM NaH 2 PO 4 , pH 7.0 (pH with NaOH). *Guanine is stable-isotopically labeled 13 C 1 15 N 3 -dG 
